First gene therapy for a blinding eye disease receives FDA approval
Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…
Let’s Talk Gene Therapy Research With Dr. Mary Sunderland & Dr. Chad Andrews (VIDEO)
On the first Tuesday of every month, Fighting Blindness Canada sends out eNews, our e-newsletter featuring the latest and most exciting research breakthroughs. Soon after each eNews, our very own Director of Research and…
Clinical Trial Updates: Gene Therapy
Many experts agree that gene replacement therapy is a novel approach to treating inherited degenerative retinal diseases, especially when the disease is caused by a single gene defect (or mutation). Gene replacement…
Pioneering Gene Therapy Trial for Blinding Eye Disease Shows Promising Long-Term Benefits
Will gene therapy be an effective treatment for blinding eye diseases? Many people who live with vision loss are waiting for an answer, while scientists and clinicians are testing a variety of…
A Sight for Sore Eyes: Using Gene Therapy and Gene Editing to Treat Blindness
Story guest authored by Erik Fraunberger, a neuroscience graduate student at the Alberta Children’s Health Research Institute in Calgary, Alberta. We live in exciting times! With each passing day, we get one step closer…
Combining Stem Cells & Gene Therapy for a ‘Smart’ Sight-Saving Treatment
Dr. Andras Nagy is world-renowned for discovering a method to create stem cells from other cells of the body, a breakthrough which overcame a major hurdle in regenerative medicine. He is also…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.